Medipyxis
blog6 min read

Surgical Wound Dehiscence Case: NPWT Bridge to Closure

A composite surgical wound dehiscence case study covering post-operative assessment, NPWT application, granulation tracking, and surgeon coordination.

D

Damon Ebanks

Medipyxis

Surgical Wound Dehiscence Case: NPWT Bridge to Closure

Surgical Wound Dehiscence Case: NPWT as a Bridge to Closure

Surgical wound dehiscence transforms a planned healing trajectory into an unplanned wound management challenge. The surgical site that was supposed to heal by primary intention is now an open wound requiring secondary or tertiary intention healing. For the wound care clinician receiving the referral, the immediate questions are: what caused the dehiscence, is the underlying surgical repair intact, and what is the fastest safe path to wound closure.

This surgical wound dehiscence case study follows a hypothetical patient through NPWT-assisted wound management and eventual closure. All patient details and clinical findings are composite and hypothetical, created for educational purposes. No real patient data is represented.


Initial Presentation: Post-Surgical Referral

The hypothetical patient is a 58-year-old female, BMI 38, with type 2 diabetes (HbA1c 7.8%), referred 10 days after an open abdominal hysterectomy. The surgical incision dehisced along the lower two-thirds of a vertical midline incision after the patient reported a coughing episode on post-operative day 8.

Wound Assessment

The dehisced segment measures 12 cm in length and 4.5 cm in width at its widest point. Depth is 3.2 cm. The wound bed shows healthy red granulation tissue with small areas of fibrinous material. There is no evidence of fascial dehiscence on gentle probing — the fascial closure is intact. No evisceration risk. No purulent drainage. Mild serous exudate. Wound margins show mild erythema without induration or warmth extending beyond 1 cm.

Contributing Factors

Several factors converge in this dehiscence:

  • Obesity. BMI of 38 increases tension on the incision line and creates a deep subcutaneous dead space where seroma or hematoma can form, both of which undermine wound edge approximation.
  • Diabetes. Impaired collagen synthesis during the proliferative phase of healing reduces tensile strength at the incision during the critical first 2 weeks.
  • Mechanical stress. The coughing episode applied sudden intra-abdominal pressure against a healing incision that had not yet developed adequate tensile strength.
  • Incision orientation. Vertical midline incisions experience more tension than transverse incisions due to the direction of abdominal wall muscle forces.

For a comprehensive guide to dehiscence risk factors and management principles, see Surgical Wound Dehiscence Management.


Treatment Plan: NPWT and Surgeon Coordination

Surgeon Communication

Before initiating any wound management plan, the wound care clinician contacts the surgeon to:

  1. Confirm fascial integrity. The surgeon reviews the assessment and agrees that the fascial closure is intact based on clinical examination. No imaging is ordered at this time.
  2. Discuss closure goals. The surgeon prefers to avoid a return to the operating room for secondary closure if the wound can be managed to heal by secondary intention or be closed at bedside once adequate granulation is achieved.
  3. Establish communication cadence. Weekly photo updates and measurement reports are sent to the surgeon's office. Any change in wound status (signs of fascial dehiscence, infection, or stalled healing) triggers immediate contact.

NPWT Initiation

NPWT is selected as the primary wound management modality. The rationale:

  • The wound is deep with a significant volume that needs granulation tissue fill before epithelialization or closure can occur.
  • NPWT provides continuous wound edge approximation (macro-deformation), drawing the wound margins toward each other and reducing the effective wound width.
  • Continuous negative pressure removes serous exudate that would otherwise pool in the subcutaneous dead space, reducing the risk of seroma formation and bacterial colonization.
  • The sealed environment reduces contamination risk in a wound located on the abdomen, where clothing friction and daily activity create constant exposure.

The NPWT device is set at -125 mmHg continuous pressure. Black foam is placed in the wound with a bridge securing the drape seal. Dressing changes are scheduled three times weekly.

For detailed guidance on NPWT indications and billing, see the NPWT Billing Guide.


Wound Progression: Weeks 1 Through 10

Weeks 1-2: The wound responds rapidly to NPWT. Granulation tissue fills the wound base aggressively. Depth decreases from 3.2 cm to 1.8 cm. Width at the widest point narrows from 4.5 cm to 3.6 cm as the macro-deformation effect draws wound edges inward. The fibrinous areas are debrided at dressing changes. Exudate decreases from moderate to scant.

Weeks 3-4: Granulation tissue is now flush with the subcutaneous plane. The wound has transitioned from a deep cavity to a shallow trough. Depth is 0.5 cm. Width is 2.8 cm. The surgeon reviews weekly photos and agrees the wound is progressing well. No signs of infection or fascial compromise.

Decision Point: Continue NPWT or Transition

At week 4, the treatment team evaluates whether to continue NPWT or transition to conventional dressings. The wound volume has decreased by approximately 80%. The remaining wound is a shallow, well-granulated trough that could heal by secondary intention with conventional moist wound healing.

The decision: transition to conventional dressings. NPWT has accomplished its primary goals (dead space elimination, granulation tissue fill, wound edge approximation). Continued NPWT on a shallow wound offers diminishing returns and adds cost and device burden for the patient.

Weeks 5-8: The wound is managed with a silver alginate primary dressing and foam secondary dressing. The wound continues to contract and epithelialize from the margins. By week 8, the wound measures 6 cm x 0.8 cm x 0 cm — essentially a linear superficial wound along the original incision line.

Weeks 9-10: Full epithelialization is achieved at week 9. The wound site shows thin neo-epithelium along the former dehiscence. The scar is wider than the original incision but intact. Week 10 confirms stable closure.


Post-Closure Considerations

Surgical Follow-Up

The patient returns to the surgeon for final assessment. The surgeon documents that the fascial closure remains intact and the wound has healed without complication. The patient is cleared for gradual return to normal activity with the instruction to avoid heavy lifting (>10 lbs) for an additional 4 weeks to allow continued collagen maturation at the fascial repair site.

Future Surgical Risk Mitigation

This patient now has a documented history of wound dehiscence. If she requires future abdominal surgery, the operative team should consider:

  • Prophylactic mesh reinforcement of the fascial closure.
  • Transverse rather than vertical incision orientation where anatomically feasible.
  • Perioperative glycemic optimization (target glucose <180 mg/dL).
  • Retention sutures or delayed removal of staples/sutures beyond the standard timeline.

Key Takeaways

  • Surgeon communication is the first step, not an afterthought. The wound care clinician must confirm fascial integrity and establish closure goals before initiating a management plan. The surgeon needs to know what is happening with their surgical site.
  • NPWT excels at dead space elimination and wound edge approximation. In post-surgical dehiscence, these mechanical effects accelerate the transition from deep open wound to shallow epithelializing surface.
  • Know when to stop NPWT. Once the wound is shallow and well-granulated, transitioning to conventional dressings reduces cost and patient burden without sacrificing healing velocity.
  • Dehiscence risk factors should inform the treatment plan. Obesity, diabetes, and incision orientation all contributed to this dehiscence. Addressing modifiable factors (glycemic control) during wound management reduces complications and supports healing.

Want to learn more about Medipyxis?

Explore how mobile wound care practices use Medipyxis to reduce denials and capture more referrals.